Ani Pharmaceuticals reported $-12913000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Aerie Pharmaceuticals AERI:US $ -18.14M 15.51M
Ani Pharmaceuticals ANIP:US $ -12913000 6.28M
Aurora Cannabis Inc ACB:CN -996333000 932.06M
Canopy Growth Corp WEED:CN C$ -1838229000 1.3B
Depomed DEPO:US $ 10.79M 0.77M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Emergent Biosolutions EBS:US $ -72M 78.4M
Endo International Ordinary Shares ENDP:US $ 68.99M 481.35M
Heron Therapeutics HRTX:US $ -62.92M 9.39M
Hikma Pharmaceutical HIK:LN 249M 6M
Knight Therapeutics Inc GUD:CN C$ -39000 14.39M
Lannett LCI:US $ -22.08M 46M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Novartis NVS:US $ 2228M 624M
Perrigo Ordinary Shares PRGO:US $ 21.7M 25M
Sun Pharmaceuticals SUNP:IN IR 21507.2M 44635.9M
Teva Pharmaceutical TEVA:IT -949000000 236M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M